Hospira, Inc. (HSP) Reports Third-Quarter 2013 Results
11/6/2013 8:43:17 AM
LAKE FOREST, Ill., Nov. 6, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the third quarter ended Sept. 30, 2013. Net sales for the quarter were $1.0 billion and adjusted* diluted earnings per share were $0.51. (Adjusted* measures exclude certain specified items as described later in this press release and the attached schedules.)
Help employers find you! Check out all the jobs and post your resume.
comments powered by